102
Participants
Start Date
October 31, 2013
Primary Completion Date
July 31, 2014
Study Completion Date
September 30, 2014
EVARREST® Fibrin Sealant Patch
Standard of Care (SoC)
Clinical Investigation Site #3, Melbourne
Clinical Investigation Site #2, Woodville South
Clinical Investigation Site #11, New York
Clinical Investigation Site #14, New York
Clinical Investigation Site #17, Pittsburgh
Clinical Investigation Site #8, Philadelphia
Clinical Investigation Site #10, Augusta
Clinical Investigation Site #13, Birmingham
Clinical Investigation Site #16, Chicago
Clinical Investigation Site #12, Chicago
Clinical Investigation Site #9, St Louis
Clinical Investigation Site #15, New Orleans
Clinical Investigation Site #1, Auckland
Clinical Investigation Site #6, Birmingham
Clinical Investigation Site #7, Cambridge
Clinical Investigation Site #4, Edinburgh
Clinical Investigation Site #5, Leeds
Ethicon, Inc.
INDUSTRY